| abstract |
The present invention relates to a general formula: ML-M2 [Wherein M or M2 may be the same or different, each independently represents a monomer unit M, and L represents a linker group that connects M 1 and M 2 by a covalent bond; The monomer units are: [Chemical 1] It is related to a novel heterocyclic compound that is a pyrazolopyridine derivative that induces FGFR dimerization, which has (Formula M)], a process for its preparation, and its therapeutic use. |